Rafael Holdings Inc (RFL)
NYSE:RFL
Want to see RFL full AI Analyst Report?
Top Page
Rafael Holdings
(NYSE:RFL)
Select Model
Select Model
Rating:49Neutral
Price Target:
$1.50
▲(22.95% Upside)
Action:ReiteratedDate:04/22/26
The score is primarily held back by weak financial performance—large, persistent losses and ongoing cash burn—despite a low-debt balance sheet. Technicals are mixed and largely neutral, while valuation is constrained by negative earnings (negative P/E). A positive corporate event (MIT license expanding Alzheimer’s IP) provides some offset but does not outweigh current operating and cash-flow pressures.
Positive Factors
High gross margins
Sustained ~84.5% gross margins indicate the company’s underlying holdings and products (IP/licensing or high-value services) can retain significant spread as revenues scale. Durable margin structure provides leverage to profits if revenue growth or milestone receipts materialize over months.
Negative Factors
Persistent cash burn
Sustained negative operating and free cash flow of -$13.6M TTM shows the company is consuming cash rather than generating it. Over months this erodes runway, forces reliance on funding events, and limits the ability to advance programs without dilutive or costly capital raises.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margins
Sustained ~84.5% gross margins indicate the company’s underlying holdings and products (IP/licensing or high-value services) can retain significant spread as revenues scale. Durable margin structure provides leverage to profits if revenue growth or milestone receipts materialize over months.
Read all positive factors
Rafael Holdings (RFL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$66.07M
Dividend YieldN/A
Average Volume (3M)81.34K
Price to Earnings (P/E)―
Beta (1Y)0.55
Revenue Growth64.73%
EPS Growth62.34%
CountryUS
Employees28
SectorReal Estate
Sector Strength53
IndustryReal Estate - Services
Share Statistics
EPS (TTM)-0.13
Shares Outstanding51,224,976
10 Day Avg. Volume101,467
30 Day Avg. Volume81,339
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.53
Price to Sales (P/S)54.22
P/FCF Ratio-2.63
Enterprise Value/Market Cap0.13
Enterprise Value/Revenue7.27
Enterprise Value/Gross Profit9.11
Enterprise Value/Ebitda-0.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Rafael Holdings Business Overview & Revenue Model
Company Description
Rafael Holdings, Inc. (RFL) is a biopharmaceutical company focused on advancing innovative therapies to treat cancer and other life-threatening diseases. The company operates primarily in the healthcare sector, with a core emphasis on developing a...
How the Company Makes Money
Rafael Holdings primarily makes money through (1) income and value changes from its investment and holding-company activities and (2) cash flows from real estate ownership. Revenue and earnings can come from rental income and other property-relate...
Rafael Holdings Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
72
Positive
Cash Flow
28
Negative
| Breakdown | TTM | Jul 2025 | Oct 2024 | Jul 2023 | Oct 2022 | Jul 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.16M | 917.00K | 637.00K | 279.00K | 410.00K | 802.00K |
| Gross Profit | 928.00K | 495.00K | 483.00K | 279.00K | 410.00K | 802.00K |
| EBITDA | -34.39M | -32.25M | -66.79M | -8.67M | -139.89M | -23.34M |
| Net Income | -33.11M | -30.52M | -34.41M | -1.88M | -124.66M | -24.54M |
Balance Sheet | ||||||
| Total Assets | 99.31M | 114.11M | 96.83M | 98.83M | 118.32M | 154.06M |
| Cash, Cash Equivalents and Short-Term Investments | 37.78M | 52.77M | 65.94M | 79.51M | 63.23M | 7.85M |
| Total Debt | 660.00K | 692.00K | 2.39M | 0.00 | 15.00M | 14.53M |
| Total Liabilities | 16.06M | 15.74M | 10.57M | 2.20M | 21.11M | 17.35M |
| Stockholders Equity | 79.17M | 94.39M | 82.19M | 100.29M | 100.52M | 122.29M |
Cash Flow | ||||||
| Free Cash Flow | -27.88M | -18.93M | -7.98M | 40.79M | -26.08M | -15.81M |
| Operating Cash Flow | -27.89M | -18.92M | -7.80M | -10.89M | -26.08M | -15.60M |
| Investing Cash Flow | -7.73M | 44.03M | -10.82M | 21.21M | -63.80M | -7.26M |
| Financing Cash Flow | 24.83M | 24.83M | -179.00K | -15.22M | 103.86M | 29.39M |
Rafael Holdings Technical Analysis
Neutral
1.22
Price Trends
1.28
Negative
1.26
Negative
1.41
Negative
Market Momentum
-0.02
Negative
49.61
Neutral
25.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RFL, the sentiment is Neutral. The current price of 1.22 is below the 20-day moving average (MA) of 1.24, below the 50-day MA of 1.28, and below the 200-day MA of 1.41, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 49.61 is Neutral, neither overbought nor oversold. The STOCH value of 25.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for RFL.
Rafael Holdings Risk Analysis
Rafael Holdings disclosed 78 risk factors in its most recent earnings report. Rafael Holdings reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Rafael Holdings Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
54 Neutral | $37.36M | -0.97 | -135.60% | ― | -38.20% | 31.79% | |
49 Neutral | $66.07M | -2.32 | -39.03% | ― | 64.73% | 62.34% | |
47 Neutral | $29.88M | -1.21 | -49.25% | ― | 25.45% | 31.31% | |
47 Neutral | $103.54M | -1.37 | -22.96% | ― | -5.86% | 24.96% |
* Real Estate Sector Average
RFL
Rafael Holdings
1.24
-0.28
-18.42%
MAYS
JW Mays
40.40
2.15
5.62%
NEN
New England Realty Associates Partnershi
60.24
-16.05
-21.04%
FTHM
Fathom Holdings
0.92
0.09
11.08%
OPAD
Offerpad Solutions
0.67
-0.44
-40.00%
STHO
Star Holdings
8.44
1.51
21.79%
Rafael Holdings Corporate Events
Business Operations and Strategy
Rafael Holdings expands Alzheimer’s portfolio with MIT license
Positive
Apr 22, 2026
On April 22, 2026, Rafael Holdings said its subsidiary Cyclo Therapeutics signed an exclusive license with MIT for a U.S. patent covering the use of cyclodextrins in treating Alzheimer’s patients who carry the ApoE4 mutation. The deal expand...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.